2 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
Follow Head and Neck: new trials by email Literature Review of Head and Neck trials Research Report on Head and Neck
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) Nivo800, Nivolumab - Hnscc, Head and Neck | Phase 1 | Recruiting | Vanderbilt-Ingram Cancer Center | 40 | 2026-07-03 | 2026-10-16 |
| A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC EPI-326 - Epidermal Growth Factor, Epidermal Growth Factor Receptor | Phase 1 | Recruiting | EpiBiologics | 110 | 2026-03-31 | 2026-10-14 |
Head and Neck Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Mouth Neoplasms (1) · Neoplasms, Squamous Cell (1)
Carcinoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Squamous Cell (1) · Lung Diseases (1) · Lung Neoplasms (1) · Mouth Diseases (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Stomatognathic Diseases (1) · Thoracic Neoplasms (1)
Nivolumab (1)
EpiBiologics (1) · Vanderbilt-Ingram Cancer Center (1)
United States (2) · South Korea (1) · Taiwan (1)